We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Risk Information in Promotional Tweets Better than Links, FDA Study Shows
Risk Information in Promotional Tweets Better than Links, FDA Study Shows
A new FDA study of character-space-limited (CSL) communications to promote prescription drugs showed that patients understood a drug’s risk better when the risk was included in an initial tweet rather than in a link to that information located on a separate landing page.